Verition Fund Management’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$982K Buy
+20,670
New +$927K 0.01% 1310
2025
Q4
Sell
-12,908
Closed -$363K 3961
2025
Q3
$363K Buy
+12,908
New +$391K ﹤0.01% 3206
2025
Q1
Sell
-4,570
Closed -$212K 3726
2024
Q4
$212K Sell
4,570
-20,523
-82% -$927K ﹤0.01% 2952
2024
Q3
$1.13M Buy
25,093
+19,054
+316% +$907K 0.01% 1798
2024
Q2
$298K Buy
+6,039
New +$246K ﹤0.01% 2349
2023
Q2
Sell
-22,574
Closed -$340K 2560
2023
Q1
$340K Buy
+22,574
New +$499K ﹤0.01% 1447

Other funds holding TWST

Verition Fund Management's TWST Position: Q1 2026 in Review

Verition Fund Management opened a new position in Twist Bioscience (TWST) in Q1 2026: 20,670 shares worth $982K. The stake represents 0.01% of the portfolio and ranks #1310 among its holdings. This is a return to the name: Verition Fund Management previously reported a position in TWST as recently as Q3 2025.

Verition Fund Management first reported a position in TWST in Q1 2023 and has held it in 6 quarters since. The position peaked at $1.13M in Q3 2024. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • Verition Fund Management held 20,670 shares of Twist Bioscience worth $982K as of Q1 2026.
  • Twist Bioscience was a new Verition Fund Management position in Q1 2026.
  • Twist Bioscience made up 0.01% of Verition Fund Management's portfolio in Q1 2026, its #1310 holding.
  • Verition Fund Management first reported a position in Twist Bioscience in Q1 2023 and has held it in 6 quarters since.
  • Verition Fund Management's Twist Bioscience position peaked at $1.13M in Q3 2024.
  • 279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.